Total Payments
$13,598
2024 Payments
$1,310
Companies
54
Transactions
828
Medicare Patients
7,084
Medicare Billing
$715,858
Payment Breakdown by Category
Food & Beverage$13,266 (97.6%)
Education$332.21 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,266 | 816 | 97.6% |
| Education | $332.21 | 12 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,635 | 255 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,963 | 93 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,585 | 77 | $0 (2024) |
| Philips Electronics North America Corporation | $770.55 | 41 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $610.65 | 26 | $0 (2024) |
| Genentech USA, Inc. | $479.40 | 34 | $0 (2021) |
| United Therapeutics Corporation | $394.00 | 17 | $0 (2024) |
| Insmed, Inc. | $312.92 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $310.02 | 30 | $0 (2019) |
| Merck Sharp & Dohme LLC | $301.55 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,310 | 71 | Boehringer Ingelheim Pharmaceuticals, Inc. ($271.22) |
| 2023 | $2,064 | 85 | AstraZeneca Pharmaceuticals LP ($383.08) |
| 2022 | $1,177 | 67 | AstraZeneca Pharmaceuticals LP ($205.21) |
| 2021 | $1,331 | 84 | AstraZeneca Pharmaceuticals LP ($229.39) |
| 2020 | $1,664 | 96 | GlaxoSmithKline, LLC. ($426.50) |
| 2019 | $1,851 | 121 | GlaxoSmithKline, LLC. ($354.99) |
| 2018 | $2,248 | 165 | GlaxoSmithKline, LLC. ($592.84) |
| 2017 | $1,953 | 139 | GlaxoSmithKline, LLC. ($349.03) |
All Payment Transactions
828 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: Pulmonology | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.80 | General |
| Category: HFCWO | ||||||
| 08/28/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Airway Clearance Device | ||||||
| 08/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ANTIBIOTIC | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Medical Device | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,869 | 2,331 | $372,711 | $163,032 |
| 2022 | 12 | 1,776 | 2,192 | $386,124 | $161,449 |
| 2021 | 12 | 2,006 | 2,669 | $458,270 | $205,843 |
| 2020 | 12 | 1,433 | 2,180 | $486,050 | $185,533 |
Total Patients
7,084
Total Services
9,372
Medicare Billing
$715,858
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 394 | $65,404 | $37,166 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 311 | 410 | $46,740 | $27,423 | 58.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 45 | 124 | $84,448 | $20,875 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $19,814 | $12,906 | 65.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 136 | $21,362 | $12,749 | 59.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 77 | 79 | $23,247 | $10,555 | 45.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 214 | 226 | $22,600 | $10,441 | 46.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 242 | 262 | $39,300 | $8,153 | 20.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 214 | 226 | $22,900 | $8,152 | 35.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 115 | $12,420 | $7,109 | 57.2% |
| 94016 | Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | Office | 2023 | 242 | 262 | $10,480 | $5,120 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $3,996 | $2,382 | 59.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 380 | 531 | $60,534 | $37,328 | 61.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 304 | $50,464 | $30,716 | 60.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 61 | 167 | $122,962 | $29,051 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 79 | 79 | $19,750 | $12,472 | 63.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 197 | 203 | $20,300 | $9,959 | 49.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 54 | $18,206 | $8,430 | 46.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 198 | 204 | $20,400 | $7,521 | 36.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 220 | 232 | $34,800 | $7,479 | 21.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 80 | $16,316 | $6,594 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 93 | $10,226 | $5,325 | 52.1% |
| 94016 | Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | Office | 2022 | 220 | 232 | $9,280 | $4,653 | 50.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $2,886 | $1,922 | 66.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 441 | 778 | $88,692 | $56,760 | 64.0% |
About Dr. Kuldeep Gill, M.D
Dr. Kuldeep Gill, M.D is a Critical Care Medicine healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184623969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kuldeep Gill, M.D has received a total of $13,598 in payments from pharmaceutical and medical device companies, with $1,310 received in 2024. These payments were reported across 828 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($13,266).
As a Medicare-enrolled provider, Gill has provided services to 7,084 Medicare beneficiaries, totaling 9,372 services with total Medicare billing of $715,858. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Fresno, CA
- Active Since 07/14/2005
- Last Updated 01/20/2016
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184623969
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,022
- NUCALA (Biological) $746.28
- OFEV (Drug) $688.41
- DUPIXENT (Biological) $405.42
- SYMBICORT (Drug) $398.17
- BREZTRI (Drug) $394.44
- TEZSPIRE (Biological) $391.89
- (8874) inCourage (Device) $371.51
- FASENRA (Drug) $360.83
- ANORO (Drug) $342.86
- STIOLTO RESPIMAT (Drug) $335.95
- UPTRAVI (Drug) $320.85
- Esbriet (Biological) $314.79
- The Vest System Model 105 Home Care (Device) $285.58
- FASENRA (Biological) $253.19
- (7999) SRC Und (Device) $233.09
- OPSUMIT (Drug) $225.40
- Arikayce (Drug) $223.77
- GLASSIA (Biological) $219.04
- Letairis (Drug) $213.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Fresno
Dr. Vijai Daniel, M.d, Mph, M.D, MPH
Critical Care Medicine — Payments: $439,189
Critical Care Medicine $439,189
Dr. Lovrdu Pyreddy, M.d, M.D
Critical Care Medicine — Payments: $13,735
Critical Care Medicine $13,735
Dr. Pankaj Mehta, Md, MD
Critical Care Medicine — Payments: $13,109
Critical Care Medicine $13,109
Dr. Madhava Narala, M.d, M.D
Critical Care Medicine — Payments: $1,070
Critical Care Medicine $1,070
Rachel Donaldson, Md, Ms, MD, MS
Critical Care Medicine — Payments: $623.84
Critical Care Medicine $623.84
Dr. Paul Goebel, M.d, M.D
Critical Care Medicine — Payments: $505.92
Critical Care Medicine $505.92